Neonatal herpes prevention: A minor public health problem in some communities

Sexually Transmitted Infections

Volumn 76, Issue 4, 2000, Pages 287-291

  Mindel, A ^a   Tideman, R L ^a   Wagner, K ^a   Page, J ^a   Marks, C ^a   Taylor, J ^b   Cunningham, A ^b   Seifert, C ^b   Berry, G ^c   Trudinger, B ^c  

^a SYDNEY EYE HOSPITAL   (Australia)

^b Centre for Virus Research Westmead Institutes of Health Research   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Herpes simplex virus; Neonatal herpes; Type specific serology

Indexed keywords

VIRUS ANTIBODY;

ADULT; ANTIBODY DETECTION; ARTICLE; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; FEMALE; HERPES SIMPLEX VIRUS; HUMAN; INFECTION RATE; INFECTION RISK; MAJOR CLINICAL STUDY; NEWBORN; NEWBORN INFECTION; PRIORITY JOURNAL; SEROPREVALENCE; VIRUS TRANSMISSION;

ADULT; AUSTRALIA; FEMALE; HERPES GENITALIS; HERPES SIMPLEX; HERPESVIRUS 1, HUMAN; HERPESVIRUS 2, HUMAN; HUMANS; INFANT, NEWBORN; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; RISK FACTORS; SEROEPIDEMIOLOGIC STUDIES;

EID: 0033817010     PISSN: 13684973     EISSN: None     Source Type: Journal    
DOI: 10.1136/sti.76.4.287     Document Type: Article

References (34)

1. 1 Whitley R, Arvin A, Prober C, et al. A controlled trial comparing vidarabine with acyclovir in neonatal herpes simplex virus infection. Infectious Diseases Collaborative Antiviral Study Group. N Engl J Med 1991;324:444-4.
2. 2 Nahmias AL, Keyserling HL, Lee FK. Herpes simplex viruses 1 and 2. In: Evans AS, ed. Viral infections of humans. Epidemiology and control. 3rd ed. New York: Plenum, 1989: 393-417.
3. 3 Malm G, Berg U, Forsgren M. Neonatal herpes simplex: clinical findings and outcome in relation to type of maternal infection. Acta Paediatr 1995;84:256-60.
4. 4 Garland SM. Neonatal herpes simplex: Royal Women's Hospital 10-year experience with management guidelines for herpes in pregnancy. Aust NZ J Obstet Gynaecol 1992;32:331-4.
5. 5 Hall SM, Glickman M. Report from the British Paediatric Surveillance Unit. Arch Dis Child 1992;65:807-9.
6. 6 Brown ZA, Vontver LA, Benedetti J, et al. Effects on infants of a first episode of genital herpes during pregnancy. N Engl J Med 1987;317:1246-51.
7. 7 Brown ZA, Selke S, Zeh J, et al. The acquisition of herpes simplex virus during pregnancy. N Engl J Med 1997;337: 509-15.
8. 8 Flemming DT, McQuillan GM, Johnson RE, et al. Herpes simplex virus type 2 in the United States 1976-1994. N Engl J Med 1997;337:1105-11.
9. 9 Mindel A, Estcourt C. Public and personal health implications of asymptomatic viral shedding in genital herpes. Sex Transm Inf 1998;74:387-8.
10. 10 Mindel A, Genital herpes - how much of a public health problem? Lancet 1998 (Supplement, Sexually Transmitted Diseases);351:sm16-sm18.
11. 11 Cunningham AL, Lee FK, Ho DWT, et al. Herpes simplex virus type 2 antibody in patients attending antenatal or STD clinics. Med J Aust 1993;158:525-8.
12. 12 Nahmias AJ, Lee FK, Beckman-Nahmias S. Seroepidemiological and sociological patterns of herpes simplex virus infection in the world. Scand J Infect Dis 1983; 69(Suppl):19-36.
13. 13 Arvin AM, Prober CG. Analysis of the epidemiology and pathogenesis of herpes simplex virus (HSV) infections in pregnant women and infants using the HSV-2 glycoprotein G antibody assay. Infect Agents Dis 1994;2:375-82.
14. 14 Frenkel LM, Garratty EM, Shen JP, et al. Clinical reactivation of herpes simplex type 2 infection in seropositive pregnant women with no history of genital herpes. Ann Intern Med 1993,118:414-18.
15. 15 Brown ZA, Benedetti, JK, Watts DH, et al. A comparison between detailed and simple histories in the diagnosis of genital herpes complicating pregnancy. Am J Obstet Gynecol 1995;172:1299-303.
16. 16 Ho DWT, Field PR, Sjogren-Jansson E, et al. Indirect ELISA for the detection of IgG and IgM antibodies with glycoprotein G (gG2). J Virol Methods 1992;36:249-64.
17. 17 Ho DWT, Field PR, Irwing WL, et al. Detection of immunoglobulin M antibodies to glycoprotein G-2 by western blot (immunodot) for diagnosis of initial herpes simplex genital infections. J Clin Microbiol 1993;31:3157-64.
18. 18 SPSS. Statistical package for the social sciences [computer program], version 7.0. Chicago, IL: SPSS Inc, 1995.
19. 19 Kulhanjian JA, Soroush V, Au DS, et al. Identification of women at unsuspected risk of contracting primary herpes simplex virus type 2 infections during pregnancy. N Engl J Med 1992;326:916-20.
20. 20 Sullivan-Bolyai L, Hull HF, Wilson C, et al. Neonatal herpes simplex virus infection in King County, Washington: increasing incidence and epidemiologic correlates. JAMA 1983;250:3059-62.
21. 21 Whitley, RJ. Herpes simplex virus infections. In: Remington S, Klein JO, eds. Infectious diseases of the fetus and newborn infant. 3rd ed. Philadelphia: WB Saunders, 1990:282-305.
22. 22 Cowan F, Johnson AM, Ashley R, et al. Antibodies to herpes simplex virus type 2 as a serological marker of sexual lifestyle in populations. BMJ 1994;309:1325-9.
23. 23 Forsgren M, Skoog E, Jeansson S, et al. Prevalence of antibodies to herpes simplex virus in pregnant women in Stockholm in 1969, 1983 and 1989: implications for STD epidemiology. Int J STD AIDS 1994;5:113-16.
24. 24 Arvaja M, Lehtinen AI, Koskela P, et al. Serological evaluation of herpes simplex virus type 1 and 2 infections in pregnancy. Sex Transm Inf 1999;75:168-71.
25. 25 Mindel A, Weller IVD, Faherty A, et al. Prophylactic oral acyclovir in recurrent genital herpes. Lancer 1984;ii:57-9.
26. 26 Straus SE, Takiff HE, Seidlin M, et al. Suppression of frequently recurring genital herpes. A placebo-controlled, double-blind trial of oral acyclovir. N Engl J Med 1984;310:1545-50.
27. 27 Douglas JM, Critchlow C, Benedetti J, et al. A double-blind study of oral acyclovir for suppression of recurrences of genital herpes simplex virus infection. N Engl J Med 1984; 310:1551-6.
28. 28 Wald A, Zeh J, Barnum G, et al. Suppression of subclinical shedding of herpes simplex virus type 2 with acyclovir. Ann Intern Med 1996;124:8-15.
29. 29 Vonau B, Low-Beer N, Barton SE, et al. Antenatal serum screening for genital herpes: a study of knowledge and attitudes of women at a central London hospital. Br J Obstet Gynaecol 1997;104:347-9.
30. 30 Hashido M, Kawana T, Tsugemi H, et al. The prevalence of type-specific antibody to herpes simplex virus type 2 in Japan. Igaku-no-ayumi 1990;152:669-70.
31. 31 Ades AE, Peckham CS, Dale GE, et al. Prevalence of antibodies to herpes simplex virus types 1 and 2 in pregnant women, and estimated rates of infection. J Epidemiol Commun Health 1989;43:53-60.
32. 32 Persson K, Mânsson A, Jönsson E, et al. Decline of herpes simplex virus type 2 and Chlamydia trachomatis infections from 1970 to 1993 indicated by a similar change in antibody pattern. Scand J Infect Dis 1995;27:195-9.
33. 33 Weinberg A, Canto CLM, Pannuti CS, et al. Herpes simplex virus type 2 infection in pregnancy: asymptomatic viral excretion at delivery and seroepidemiologic survey of two socioeconomically distinct populations in Sao Paulo, Brazil. Rev Inst Med Trop Sao Paulo 1993;35:285-90.
34. 34 Randolph AG, Washington AE, Prober CG. Cesarean delivery for women presenting with genital herpes lesions. Efficacy, risks and costs. JAMA 1993;270:77-82.